Orphenadrine Citrate
Product Images NDC 33261-088

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 33261-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Orphenadrine Citrate Chemical Structure (Orphenadrine Cit Tabs Novel 1)

Chemical structure of Orphenadrine Citrate showing the molecular arrangement of its active ingredients, including a diphenylpropylamine derivative and citrate moiety.*

FDA Label Image

Image Label (Orphenadrine Cit Tabs Novel 2)

Packaging label for Orphenadrine Citrate Extended-Release (ER) 100 mg tablets from Aidarex Pharmaceuticals LLC. The label states it contains 30 tablets per bottle, with each tablet containing 100 mg of Orphenadrine Citrate. It lists the product NDC as 33261-0088-30 and includes generic equivalence information to Norflex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.